Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
8 Upcoming Dividend Increases During Volatile Times
01:43pm, Friday, 04'th Apr 2025
8 Upcoming Dividend Increases During Volatile Times
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
07:06am, Wednesday, 02'nd Apr 2025
Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to scree
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
04:23pm, Tuesday, 01'st Apr 2025
SECAUCUS, N.J. , April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial resu
Is Quest Diagnostics Stock Worth Holding Onto Right Now?
09:10am, Thursday, 27'th Mar 2025
Strong momentum in Advanced Diagnostics and strategic acquisitions continues to attract investors to DGX.
DGX Stock Set to Benefit From New Google Cloud Partnership
09:21am, Friday, 21'st Mar 2025
Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.
Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight
03:16pm, Wednesday, 19'th Mar 2025
Betting on AI-driven precision oncology companies presents a compelling long-term opportunity for investors. Some of the stocks in focus are BTAI, TEM and DGX.
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
07:52am, Wednesday, 19'th Mar 2025
Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per share (EPS) expected to grow at 7-9% CAGR Reaffirms guidance
Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
09:00am, Tuesday, 18'th Mar 2025
SUNNYVALE, Calif. and SECAUCUS, N.J.
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?
11:15am, Monday, 03'rd Mar 2025
DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions.
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
09:55am, Tuesday, 25'th Feb 2025
DGX stays on investors' radars due to its robust prospects in Advanced Diagnostics and progress in the acquisition strategy.
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
08:00am, Monday, 24'th Feb 2025
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.
Quest Diagnostics to Host Investor Day on March 19, 2025
04:54pm, Thursday, 13'th Feb 2025
SECAUCUS, N.J. , Feb. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and finan
GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
10:56am, Monday, 10'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats
10:15am, Monday, 10'th Feb 2025
Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth for DGX in the fourth quarter of 2024.
